A Study of Clinical Profile of Patients of Carcinoma Prostate - A Descriptive Study

Background: Wide variation exists internationally for prostate cancer rates due to differences in detection practices, treatment, and lifestyle and genetic factors. With increase in life expectancy, adoption of newer lifestyles and screening using prostate specific antigen (PSA), the incidence of prostate cancer is on rise. Globally prostate cancer is the second most frequently diagnosed cancer and sixth leading cause of cancer death in men. Method: This is a descriptive study carried out between Aug 2016 and June 2019 on 30 cases carcinoma prostate patients. Result: 60 % patients fell in the age group of 50-70 yrs with 60 % patients falling in mild symptomatic score. Among the patients 60 % patients had serum PSA level greater than20 ng/ml at diagnosis and 70 % of the patients had moderately differentiated tumours at presentation. At diagnosis 46.6 % patients already had metastasis.50 % patient were offered active surveillance, 40 % of the patients were offered androgen deprivation therapy as treatment.